Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer

The formation of premetastatic niches creates a fertile environment for the seeding of disseminated cancer cells in selected secondary organs. This is crucial for the development of metastasis in various malignancies, including breast cancer (BC). We previously reported that the loss of FBXW7 in bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Takaaki, Noda, Miwa, Kogawa, Takahiro, Kitagawa, Dai, Hayashi, Naoki, Jomori, Takahito, Nakanishi, Yoichi, Nakayama, Keiichi I., Ohno, Shinji, Mimori, Koshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060487/
https://www.ncbi.nlm.nih.gov/pubmed/31943636
http://dx.doi.org/10.1111/cas.14306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060487/
https://www.ncbi.nlm.nih.gov/pubmed/31943636
http://dx.doi.org/10.1111/cas.14306

Ejemplares similares